Outlook Therapeutics Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update
December 27, 2024 08:05 ET | Source: Outlook Therapeutics, Inc. LYTENAVA™ is…
Outlook Therapeutics Announces Executive Leadership Transition
December 03, 2024 16:30 ET | Source: Outlook Therapeutics, Inc. ISELIN, N.J.,…